PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nottingham Clinical Trials Unit, University of Nottingham, Building 42, University Park, Nottingham, NG7 2RD, UK. eleanor.mitchell@nottingham.ac.uk.\', \'Birmingham Clinical Trials Unit (BCTU), Institute of Applied Health Research, College of Medical and Dental Sciences, Public Health Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.\', \'Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, AB25 2ZD, UK.\', \'NMAHP Research Unit, Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.\', \'Liverpool Clinical Trials Centre, University of Liverpool, a member of the Liverpool Health Partners, Liverpool, L69 3BX, UK.\', \'Nottingham Clinical Trials Unit, University of Nottingham, Building 42, University Park, Nottingham, NG7 2RD, UK.\', \'Oxford Trauma, University of Oxford, NDORMS, Kadoorie Centre, Level 3, John Radcliffe Hospital, Oxford, OX3 9DU, UK.\', \'Leicester Clinical Trials Unit, College of Life Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04711-6
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32917258
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • It is unprecedented: trial management during the COVID-19 pandemic and beyond.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all